email@example.com Contact Person Mr. Joan Perelló Bestard Products/Services SNF472 is an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis. After having completed phase Ia studies with healthy volunteers and a phase Ib/IIa study with haemodialysis patients, Sanifit raised a series C funding round of $41.3M (36.6M). Sanifit is currently running a phase IIb study in ESRD and extending the orphan program in calciphylaxis into phase II/III clinical trials.
firstname.lastname@example.org mobile +34 637 057 432 Contact Person Mr. Luis Ruiz Avila Products/Services Spherium is a clinical stage portfolio company that sources its pipeline from academic sources, with a lean venture builder business model. The company has currently 8 active projects, four of them in clinical stage and four in preclinical stage. The company acquires rights to develop and commercialize therapeutic programs from academic research centers, hospitals or universities, and implement development strategies towards a relevant milestone, normally phase II proof of concept. Trademarks MUCOMEL.